Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

AEON AEON Biopharma Inc

0,1401

-0,0455 (-24,52%)

14 Jan 2025 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

07/29/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Oleg Grodnensky

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

AEON Biopharma (AMEX:AEON)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse AEON Biopharma

AEON Biopharma (AMEX:AEON)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse AEON Biopharma

Actualités AEON Biopharma Inc

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Lundi 13 Janvier 2025 ( il y a 9 heures) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Mardi 7 Janvier 2025 ( il y a 7 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Lundi 6 Janvier 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Lundi 6 Janvier 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 20 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mercredi 13 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mercredi 13 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Lundi 7 Octobre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 5 Septembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 5 Septembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 5 Septembre 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Plus d'articles sur AEON Biopharma Inc

China Natural Resources

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales